Yunhua N Jeng

Title: Innovations of Yunhua N Jeng

Introduction

Yunhua N Jeng is a notable inventor based in Chesterfield, MO (US). He has made significant contributions to the field of biotechnology, particularly in the development of formulations for the extended release of biologically-active polypeptides. With a total of 6 patents to his name, Jeng's work has the potential to impact various applications in medicine and animal health.

Latest Patents

One of Jeng's latest patents is titled "Non-aqueous injectable formulations for extended release of somatotropin." This invention provides compositions that allow for the extended release and enhanced bioavailability of biologically-active polypeptides following parenteral delivery to an animal. The compositions comprise somatotropin, a bioavailability-enhancing constituent (BEC), and a substantially non-aqueous, hydrophobic excipient. The BEC may include amino acids, hydroxamate derivatives, non-reducing carbohydrates, oxo-acid salts, or a mixture of these compounds.

Another significant patent is "Non-aqueous surfactant-containing formulations for extended release of somatotropin." This invention also focuses on compositions comprising biologically-active somatotropin formulated for extended release. The formulations include a first BEC, typically a surfactant or a cyclodextrin compound, and optionally a second BEC, which may consist of similar components as mentioned in the previous patent.

Career Highlights

Yunhua N Jeng is currently associated with Monsanto Technology LLC, where he continues to innovate in the field of biotechnology. His work has been instrumental in advancing the understanding and application of somatotropin formulations.

Collaborations

Jeng has collaborated with notable coworkers, including Kanaiyalal R Patel and Daniel Nicholas Heintz. These collaborations have contributed to the successful development of his patented formulations.

Conclusion

Yunhua N Jeng's contributions to biotechnology through his innovative patents demonstrate his commitment to enhancing the field of biologically-active polypeptides. His work continues to pave the way for advancements in medical and veterinary applications.